Connect with us

Trends

Global AI in Diabetes Management Market is Set for a Rapid Growth

The global artificial intelligence in diabetes management market accounted for USD 82.72 million in 2017 and is expected to reach approximately USD 1422.52 million by 2024, growing at a CAGR of around 47.23 percent between 2018 and 2024. Diabetes is a group of metabolic disorder characterized by a lack of production of a sufficient amount of insulin by the human pancreas. At present, the major part of the world is suffering from type 2 diabetes to a greater extent. Genetics and an unhealthy lifestyle are considered as major causes of diabetes mellitus. Government programs are running across the globe in order to control diabetes. Many software companies come with an idea of various applications in diabetes management which would help in controlling and managing diabetes. Increasing use of mobile phones allows these companies to design apps which directly or indirectly help to manage the diabetes mellitus.

The global artificial intelligence in diabetes management market is expected to witness the excellent growth. The growth is mainly associated with the increasing prevalence of geriatric population across the world. In addition, rising prevalence of metabolic disorder coupled with increasing adoption of torpid or sedentary lifestyle also contributes in driving the growth of artificial intelligence in diabetes management market. However, few factors such as government regulation, lack of awareness, and high cost are the key restraints limiting the growth of artificial intelligence in diabetes management market. Nonetheless, various research and technological advancements are considered as better opportunities that help in bringing new growth avenue for artificial intelligence in diabetes management market.

Based on device type, the global artificial intelligence in diabetes management market is segmented into four types: glucose monitoring devices, diagnostic devices, insulin delivery devices, and other devices. Glucose monitoring devices segment accounted for the largest market share in the year 2017 and is expected to remain dominant. Based on technique type, the global artificial intelligence in diabetes management market is classified into two types’ case-based reasoning and intelligent data analysis. Case-based reasoning accounted for the largest market share in the year 2017. This growth is attributed to an increasing number of diabetes cases across the world with the different type of causes.

Based on region, the global artificial intelligence in diabetes management market is fragmented into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America was the largest market in terms of revenue. North America held more than 42 percent of market share in the year 2017. Technological advancement in the software industry is the major driver for the growth of artificial intelligence in diabetes management in the North America region. Furthermore, Asia Pacific region will grow with the highest CAGR from 2018 to 2024. This growth is due to the increasing number of diabetic disorders among the adults.

The report covers company profiles and company market share, reimbursement policy of the key participants operating in the global artificial intelligence in diabetes management market. Some of the key players included in the report are Apple Inc., Diabnext, Glooko Inc., Google Inc., IBM Corporation, Tidepool, and Vodafone Group Plc. – Zion Market Research

Copyright © 2024 Medical Buyer

error: Content is protected !!